Michelle McMurry-Heath
At a glance: Michelle McMurry-Heath is Director at Bioventus (BVS). Their latest SEC Form 4, filed Mar 13, 2026, reported a sale of $105K. On file: 0 purchase lines ($0) and 3 sale lines ($295K).
Disclosed holdings: about $445K of BVS stock: 44,997 shares reported on their latest Form 4 (filed Mar 13, 2026), valued at the Nov 20, 2026 close of $9.90. This counts only BVS shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Bioventus Inc. (BVS); Director at Revvity, Inc. (RVTY)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Michelle McMurry-Heath's InsiderPrint
3 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 3 times a year, typically $105K a trade.
- Bump outward: a purchase (0)
- Dent inward: a sale (3)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Brett MoyerCFO · DVLT · 97% match
- George R. Mrkonic Jr.Director · AZO · 96% match
- Sylvia AcevedoDirector · CRDO · 94% match
- Elizabeth M. SchwartingDirector · AMBA · 94% match
- Sven WehrweinDirector · ATRC · 94% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
Follow Michelle McMurry-Heath
Get one email when Michelle McMurry-Heath files a new purchase or sale. Free.
At most one email a day about Michelle McMurry-Heath, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.